Pitfalls in Urine Cytology: A Case of Fumarate Hydratase‐Deficient Renal Cell Carcinoma Initially Diagnosed as High‐Grade Urothelial Carcinoma
Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare, aggressive, hereditary subtype of renal cancer that requires careful diagnostic considerations. We report a case of a 33-year-old Asian woman who presented with a 20-day history of hematuria. Imaging studies revealed a solid tumor in the lower pole of the right kidney with lymph node metastases. Urinary cytology revealed benign squamous cells, inflammatory cells, and atypical epithelial cells, suggestive of high-grade urothelial carcinoma. Following a right nephrectomy, the tumor displayed papillary structures composed of cells exhibiting atypical, elongated nuclei with eosinophilic nucleoli and peripheral halos. Immunohistochemical staining demonstrated negative FH expression. Genetic analysis identified a somatic missense mutation in the FH gene, confirming the diagnosis of FH-deficient RCC. This case highlights the importance of integrating cytological, histological, and genetic analyses for accurate diagnosis of FH-deficient RCC.
Authors
- Qiu Rao (ORCID: https://orcid.org/0000-0002-2674-1937)
- Kai Cheng (ORCID: https://orcid.org/0009-0009-3914-4144)
- Wei Bao (ORCID: https://orcid.org/0000-0002-7301-5786)
- Xuelian Zhang (ORCID: https://orcid.org/0000-0003-2925-9457)
- Xiaodie Zhou
- Xiaotong Wang
Institutions
- Nanjing General Hospital of Nanjing Military Command (CN)
- Kingmed Diagnostics (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Diagnostic Cytopathology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1002/dc.25409
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- National Natural Science Foundation of China